HEALTH-RELATED QUALITY OF LIFE FROM THE INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE AMONG PATIENTS WITH ULCERATIVE COLITIS STRATIFIED BY PRIOR AND CONCOMITANT THERAPIES: RESULTS FROM THE ETRASIMOD ELEVATE UC CLINICAL PROGRAMME

Alessandro Armuzzi  ¹     David T. Rubin  ²     Stefan Schreiber  ³     Julian Panés  ⁴     Marc Fellmann  ⁵     Lauren Bartolome  ⁶     Martina Goetsch     Abhishek Bhattacharjee  ⁷     Joseph Wu  ⁸     María Chaparro  ^{9, 10, 11}     Marla C. Dubinsky  ^12    
1 IBD Unit, IRCCS Humanitas Research Hospital, Milan, Italy
² University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, United States
³ University Hospital Schleswig-Holstein, Kiel University, Kiel, Germany
⁴ Formerly of Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain
⁵ Pfizer AG, Zürich, Switzerland
⁶ Pfizer Inc, New York, United States
⁷ Pfizer Healthcare India Pvt. Ltd, Chennai, India
⁸ Pfizer Inc, Groton, United States
⁹ Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS Princesa), Madrid, Spain
¹⁰ Universidad Autónoma de Madrid (UAM), Madrid, Spain
¹¹ Centro de Investigacíon Biomédica en Red de Enfermedades Hepáticas y Digestivas
¹² Icahn School of Medicine at Mount Sinai, New York, United States

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)